Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions

Area of Science:

• Natural Products Chemistry
• Pharmacology
• Oncology

Background:

• Alternol and Alteronol are small compounds derived from a mutant fungus found in *Taxus brevifolia* bark.
• These compounds exhibit significant preclinical anti-cancer activities.
• Their mechanism involves targeting specific cancer cell vulnerabilities.

Purpose of the Study:

• To investigate the anti-cancer mechanisms and therapeutic potential of Alternol and Alteronol.
• To evaluate their efficacy and safety in preclinical cancer models.

Main Methods:

• Compounds isolated from fungal fermentation (*Taxus brevifolia*).
• In vitro studies: cancer cell culture models assessing cell cycle arrest and apoptosis.
• In vivo studies: mice xenograft models evaluating tumor growth suppression and toxicity.

Main Results:

• Alternol/Alteronol attenuate survival pathways, alter cell cycle regulators, and induce reactive oxygen species (ROS) via xanthine dehydrogenase activation.
• Compounds disrupt cancer cell metabolism by inhibiting specific Krebs cycle enzymes, sparing benign cells.
• Demonstrated significant tumor growth suppression in mice xenografts with a therapeutic index >30-fold and no obvious host toxicity.

Conclusions:

• Alternol and Alteronol exhibit potent, selective anti-tumor effects through multiple mechanisms.
• These compounds induce cell cycle arrest and apoptosis in cancer cells.
• High therapeutic potential for development as novel anti-tumor therapeutics with a favorable safety profile.